Lebanon vs Lithuania: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Lebanon
0.1%
in 2024
Lithuania
0.1%
in 2024
Lebanon rank
112th
Lithuania rank
112th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Lebanon
- Lithuania
How they compare
Lebanon currently reports 0.1% against 0.1% in Lithuania, a difference of 0.0%.
Across all 10 years both countries report, Lithuania has been ahead every year.
Lebanon ranks 112th and Lithuania ranks 112th of 215 countries.
Lithuania has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lebanon | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 0.1% | 0.1% | Lithuania |
| 2020s | 0.1% | 0.1% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Lebanon or Lithuania?
- Lebanon, at 0.1% against 0.1% in Lithuania as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Lebanon and Lithuania?
- 0.0%, with Lebanon ahead.
- How many years of comparable data are there for Lebanon and Lithuania?
- 10 years are reported by both, from 2015 to 2024.
- How do Lebanon and Lithuania rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Lebanon ranks 112th and Lithuania ranks 112th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.